A carregar...
Economic impacts of introducing diagnostics for mild cognitive impairment Alzheimer's disease patients
INTRODUCTION: Disease-modifying treatments for Alzheimer's disease (AD) are likely to be offered only to patients with molecular evidence for Alzheimer pathology and expanded to patients with prodromal AD. We calculated the potential future costs of expanding the number of positron emission tom...
Na minha lista:
| Publicado no: | Alzheimers Dement (N Y) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6709060/ https://ncbi.nlm.nih.gov/pubmed/31463360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2019.06.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|